Rankings
▼
Calendar
BCYC Q1 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$374M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+26.8% YoY
Gross Profit
$5M
100.0% margin
Operating Income
-$42M
-853.8% margin
Net Income
-$39M
-797.9% margin
EPS (Diluted)
$-1.30
QoQ Revenue Growth
+53.7%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$49M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$429M
Total Liabilities
$186M
Stockholders' Equity
$243M
Cash & Equivalents
$294M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$4M
+26.8%
Gross Profit
$5M
$4M
+26.8%
Operating Income
-$42M
-$27M
-52.7%
Net Income
-$39M
-$28M
-41.7%
← FY 2023
All Quarters
Q2 2023 →